Chlorpromazine Hydrochloride USP For Compounding (API)

Chlorpromazine hydrochloride USP is an active pharmaceutical ingredient (API) also known as a traditional antipsychotic medication. It is a derivative of phenothiazine and is used to treat various psychiatric disorders such as schizophrenia, bipolar disorder, and severe behavioral problems. It works by blocking the neurotransmitter dopamine in the brain, helping to reduce symptoms of psychosis and agitation. Additionally, chlorpromazine hydrochloride USP also has sedative and antiemetic (anti-nausea and vomiting) properties.

Chlorpromazine Hydrochloride USP for compounding is commonly used in the formulation of medications for the treatment of certain psychiatric disorders, including schizophrenia, bipolar disorder, and severe behavioral problems in children. It is an antipsychotic medication that helps to control the symptoms of these disorders, such as hallucinations, delusions, and agitation. It may also be used in the treatment of hiccups and nausea in certain medical conditions. It works by affecting the balance of chemicals in the brain, specifically dopamine and serotonin, which are involved in regulating mood, thinking, and behavior.

CAS Number: 69-69-0

Property: Light Sensitive | Hazardous Material